Abstract:Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent chronic liver diseases worldwide with an unclear mechanism. Long non-coding RNAs (lncRNAs) have recently emerged as important regulatory molecules. To better understand NAFLD pathogenesis, lncRNA and messenger RNA (mRNA) microarrays were conducted in an NAFLD rodent model. Potential target genes of significantly changed lncRNA were predicted using cis/trans-regulatory algorithms. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were then performed to explore their function. In the current analysis, 89 upregulated and 177 downregulated mRNAs were identified, together with 291 deregulated lncRNAs. Bioinformatic analysis of these RNAs has categorized these RNAs into pathways including arachidonic acid metabolism, circadian rhythm, linoleic acid metabolism, peroxisome proliferator-activated receptor (PPAR) signaling pathway, sphingolipid metabolism, steroid biosynthesis, tryptophan metabolism and tyrosine metabolism were compromised. Quantitative polymerase chain reaction (qPCR) of representative nine mRNAs and eight lncRNAs (named fatty liver-related lncRNA, FLRL) was conducted and this verified previous microarray results. Several lncRNAs, such as FLRL1, FLRL6 and FLRL2 demonstrated to be involved in circadian rhythm targeting period circadian clock 3 (Per3), Per2 and aryl hydrocarbon receptor nuclear translocator-like (Arntl), respectively. While FLRL8, FLRL3 and FLRL7 showed a potential role in PPAR signaling pathway through interaction with fatty acid binding protein 5 (Fabp5), lipoprotein lipase (Lpl) and fatty acid desaturase 2 (Fads2). Functional experiments showed that interfering of lncRNA FLRL2 expression affected the expression of predicted target, circadian rhythm gene Arntl. Moreover, both FLRL2 and Arntl were downregulated in the NAFLD cellular model. The current study identified lncRNA and corresponding mRNA in NAFLD, providing new insight into the pathogenesis of NAFLD. Moreover, we identified a new lncRNA FLRL2, that might participate NAFLD pathogenesis mediated by Arntl.

Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications

Circular RNAs in Non-Alcoholic Fatty Liver Disease: Functions and Clinical Significance.

Circular RNA As an Epigenetic Regulator in Chronic Liver Diseases

LncRNA and circRNA in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review

Noncoding RNAs in Alcoholic Liver Disease

Circular Rna In Liver: Health And Diseases

Circular RNA expression profiles and features in NAFLD mice: a study using RNA-seq data

Long Non-Coding Rna Profiling In A Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight Into Pathogenesis

Profile Analysis and Functional Modeling Identify Circular RNAs in Nonalcoholic Fatty Liver Disease As Regulators of Hepatic Lipid Metabolism

Circrna Expression Pattern And Circrna-Mirna-Mrna Network In The Pathogenesis Of Nonalcoholic Steatohepatitis

Circular RNAs: Rising stars in lipid metabolism and lipid disorders

Circular RNA as a Novel Biomarker and Therapeutic Target for HCC

Value of Circular RNA in the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease

Circular RNAs: a Novel Tool in the Development of Digestive System Biomarker

The Function of Long Non-Coding RNA in Non-Alcoholic Fatty Liver Disease

The Function and Regulation Network Mechanism of Circrna in Liver Diseases

The Novel Roles of Circular RNAs in Metabolic Organs

Role of Noncoding RNA in Development of Nonalcoholic Fatty Liver Disease

Progress and Prospects of Circular RNAs in Hepatocellular Carcinoma: Novel insights into their function

Role of noncoding RNAs in liver fibrosis

Circular RNAs in the Pathogenesis of Atherosclerosis